Certain MS symptoms at the time of diagnosis were linked to greater impairment later in life, according to a small new study.

A global medical device company awarded its highest honor to the Urology Department at Horizon Health. Axonics presented its ...

Urinary incontinence, constipation, or a feeling of pain/heaviness in your pelvic area are issues that some women may be ...

The annual Helen Hamlyn Design Awards, organised by the Royal College of Art’s Helen Hamlyn Centre for Design (HHCD) - have ...

The Montreal Children's Hospital (MCH) of the McGill University Health Centre (MUHC) is proud to announce the opening of its ...

Axonics announced today that it received regulatory approval in Australia for its R20 rechargeable sacral neuromodulation ...

Suspected CES in a student travelling in Indonesia highlights the need for a systematic approach to remote management ...

Global Surgical Sphincteroplasty Market is valued at approximately USD 1.48 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.67% over the forecast period 2024-2032.

AXNX's R20 rechargeable SNM system, offering long-lasting treatment for bladder and bowel dysfunction, gains approval in Australia.

The Montreal Children's Hospital (MCH) of the McGill University Health Centre (MUHC) is proud to announce the opening of its ...